„First Line“

Suchergebnisse

3.416 Treffer

• Taiwan Nationwide Study of First-Line ALK–TKI Therapy in ALK-Positive Lung Adenocarcinoma
  Zheng, Zhe-Rong ; Wu, Jia-Jun ; Chiang, Chun-Ju ; Chen, Tzu-I ; Chen, Kun-Chieh ; Chu, Cheng-Hsiang ; Lin, Sheng-Yi ; Yu, Sung-Liang ; Lee, Wen-Chung ; Liu, Tsang-Wu ; Chang, Gee-Chen
• Pharmacokinetics-pharmacodynamics of first-line antitubercular drugs: a comparative study in tuberculosis patients with and without concomitant diabetes mellitus
  Mondal, Sourav ; Roy, Vandana ; Meshram, Girish Gulab ; Khanna, Ashwani ; Velpandian, Thirumurthy ; Garg, Sandeep
• Predicting first-line VEGFR-TKI resistance and survival in metastatic clear cell renal cell carcinoma using a clinical-radiomic nomogram
  Wang, Yichen ; Zhang, Xinxin ; Wang, Sicong ; Shi, Hongzhe ; Zhao, Xinming ; Chen, Yan
• Do Women with Urinary Incontinence and Pelvic Organ Prolapse Receive Optimal First-Line Treatment?
  Bø, Kari ; Engh, Marie Ellstrøm ; Teig, Catherine Joyce ; Tennfjord, Merete Kolberg
• Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study
  Nakazawa, Nobuhiro ; Sohda, Makoto ; Hosoi, Nobuhiro ; Watanabe, Takayoshi ; Kumakura, Yuji ; Yamashita, Toshiki ; Tanaka, Naritaka ; Saito, Kana ; Kimura, Akiharu ; Kasuga, Kengo ; Nakazato, Kenji ; Yoshinari, Daisuke ; Shimizu, Hisashi ; Ubukata, Yasunari ; Hosaka, Hisashi ; Sano, Akihiko ; Sakai, Makoto ; Ogawa, Hiroomi ; Shirabe, Ken ; Saeki, Hiroshi
• ASO Author Reflections: The Gustave Roussy Immune Score May Be a Useful Biomarker for Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Gastric Cancer
  Nakazawa, Nobuhiro ; Sano, Akihiko ; Sakai, Makoto ; Shirabe, Ken ; Saeki, Hiroshi
• ASO Visual Abstract: Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score—A Multicenter Study
  Nakazawa, Nobuhiro ; Sohda, Makoto ; Hosoi, Nobuhiro ; Watanabe, Takayoshi ; Kumakura, Yuji ; Yamashita, Toshiki ; Tanaka, Naritaka ; Saito, Kana ; Kimura, Akiharu ; Kasuga, Kengo ; Nakazato, Kenji ; Yoshinari, Daisuke ; Shimizu, Hisashi ; Ubukata, Yasunari ; Hosaka, Hisashi ; Sano, Akihiko ; Sakai, Makoto ; Ogawa, Hiroomi ; Shirabe, Ken ; Saeki, Hiroshi
• Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion (PHP) as First-Line or Second-Line Therapy for Metastatic Uveal Melanoma
  Ghali, Helana ; Dugan, Michelle M. ; Aflatooni, Shaliz ; Boby, Aleena ; DePalo, Danielle K. ; Laborde, José ; Choi, Junsung ; Ahmed, Altan F. ; Zager, Jonathan S.
• Atomic functions and direct methods for solving the Fredholm integral equation of the first kind in the problem on synthesis of linear antennas
  Basarab, M. A. ; Kravchenko, V. F. ; Pustovoit, V. I.
• Feasibility, efficacy, and safety of core needle biopsy as a first-line method for cervical lymphadenopathy
  Jeong, Chan Yeop ; Noh, Byeong-Joo ; Na, Dong Gyu
• Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States
  Monk, Bradley J. ; Mens, Sophie van ; Hale, Oliver ; Boer, Jennifer ; Hees, Frank van ; Swami, Shilpi ; Muston, Dominic ; Tekin, Cumhur ; Keefe, Steve ; Monberg, Matthew
• Cryoballoon pulmonary vein isolation as first-line treatment of typical atrial flutter: long-term outcomes of the CRAFT trial
  Calvert, Peter ; Ding, Wern Yew ; Das, Moloy ; Tovmassian, Lilith ; Tayebjee, Muzahir H. ; Haywood, Guy ; Martin, Claire A. ; Rajappan, Kim ; Bates, Matthew G. D. ; Temple, Ian Peter ; Reichlin, Tobias ; Chen, Zhong ; Balasubramaniam, Richard N. ; Sticherling, Christian ; Ronayne, Christina ; Clarkson, Nichola ; Morgan, Maureen ; Barton, Janet ; Kemp, Ian ; Mahida, Saagar ; Gupta, Dhiraj
• Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
  Watanabe, Sho ; Shimoi, Tatsunori ; Nishikawa, Tadaaki ; Kawachi, Asuka ; Okuma, Hitomi Sumiyoshi ; Tokura, Momoko ; Yazaki, Shu ; Mizoguchi, Chiharu ; Arakaki, Motoko ; Saito, Ayumi ; Kita, Shosuke ; Yamamoto, Kasumi ; Kojima, Yuki ; Sudo, Kazuki ; Noguchi, Emi ; Yoshida, Akihiko ; Kawai, Akira ; Fujiwara, Yasuhiro ; Yonemori, Kan
• Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma—a retrospective, international, multicentric AGEO study
  Bergen, Elisabeth S. ; Pilla, Lorenzo ; Auclin, Edouard ; Ilhan-Mutlu, Aysegül ; Prager, Gerald ; Pietrantonio, Filippo ; Antista, Maria ; Ghelardi, Filippo ; Basile, Debora ; Aprile, Giuseppe ; Longarini, Raffaella ; Hautefeuille, Vincent ; Tougeron, David ; Artru, Pascal ; Mabro, May ; Drouillard, Antoine ; Roth, Gael ; Ben Abdelghani, Meher ; Clement, Inès ; Toullec, Clemence ; Mineur, Laurent ; Guimbaud, Rosine ; Taieb, Julien ; Zaanan, Aziz
• First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future Trials
  Cabibbo, Giuseppe ; Reig, Maria ; Celsa, Ciro ; Torres, Ferran ; Battaglia, Salvatore ; Enea, Marco ; Rizzo, Giacomo Emanuele Maria ; Petta, Salvatore ; Calvaruso, Vincenza ; Di Marco, Vito ; Craxì, Antonio ; Singal, Amit G. ; Bruix, Jordi ; Cammà, Calogero
• Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives
  Gallo, Marco ; Malandrino, Pasqualino ; Fanciulli, Giuseppe ; Rota, Francesca ; Faggiano, Antongiulio ; Colao, Annamaria
• A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302)
  Lara, Primo N. ; Villanueva, Luis ; Ibanez, Carolina ; Erman, Mustafa ; Lee, Jae Lyun ; Heinrich, Daniel ; Lipatov, Oleg Nikolaevich ; Gedye, Craig ; Gokmen, Erhan ; Acevedo, Alejandro ; Semenov, Andrey ; Park, Se Hoon ; Gafanov, Rustem Airatovich ; Kose, Fatih ; Jones, Mark ; Du, Xiaoqi ; Munteanu, Mihaela ; Perini, Rodolfo ; Choueiri, Toni K. ; Motzer, Robert J.
• REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
  Martin-Broto, Javier ; Valverde, Claudia ; Hindi, Nadia ; Vincenzi, Bruno ; Martinez-Trufero, Javier ; Grignani, Giovanni ; Italiano, Antoine ; Lavernia, Javier ; Vallejo, Ana ; Tos, Paolo Dei ; Le Loarer, Francois ; Gonzalez-Campora, Ricardo ; Ramos, Rafael ; Hernández-Jover, Diana ; Gutierrez, Antonio ; Serrano, Cesar ; Monteagudo, Maria ; Letón, Rocio ; Robledo, Mercedes ; Moura, David S. ; Martin-Ruiz, Marta ; López-Guerrero, Jose A. ; Cruz, Julia ; Fernandez-Serra, Antonio ; Blay, Jean-Yves ; Fumaga
• Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data
  Mohammadi, Mahmoud ; IJzerman, Nikki S. ; Hollander, Dide ˜denœ ; Bleckman, Roos F. ; Oosten, Astrid W. ; Desar, Ingrid M. E. ; Reyners, An K. L. ; Steeghs, Neeltje ; Gelderblom, Hans
• Overall survival results from the randomized phase 2 study of palbociclib in combination with letrozole versus letrozole alone for first-line treatment of ER+/HER2− advanced breast cancer (PALOMA-1, TRIO-18)
  Finn, Richard S. ; Boer, Katalin ; Bondarenko, Igor ; Patel, Ravindranath ; Pinter, Tamas ; Schmidt, Marcus ; Shparyk, Yaroslav V. ; Thummala, Anu ; Voitko, Nataliia ; Bananis, Eustratios ; McRoy, Lynn ; Wilner, Keith ; Huang, Xin ; Kim, Sindy ; Slamon, Dennis J. ; Ettl, Johannes